TrialPsychiatry and clinical neurosciences2023

Asenapine add-on treatment for schizophrenia adults who received antipsychotics: A 52-week, open-label study.

Taro Kishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.